Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis

Introduction: Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus. As murine models of LN are valuable tools to better understand its pathophysiology and to search for new effective treatments, we investigated the effects of the bioflavonoid quercetin on pris...

Full description

Bibliographic Details
Main Authors: Mariane dos Santos, Priscila Tamar Poletti, Gaia Favero, Alessandra Stacchiotti, Francesca Bonomini, Carolina Caruccio Montanari, Silvia Regina Bona, Norma Possa Marroni, Rita Rezzani, Francisco Veríssimo Veronese
Format: Article
Language:English
Published: Taylor & Francis Group 2018-02-01
Series:Autoimmunity
Subjects:
Online Access:http://dx.doi.org/10.1080/08916934.2018.1442828
_version_ 1827817511492517888
author Mariane dos Santos
Priscila Tamar Poletti
Gaia Favero
Alessandra Stacchiotti
Francesca Bonomini
Carolina Caruccio Montanari
Silvia Regina Bona
Norma Possa Marroni
Rita Rezzani
Francisco Veríssimo Veronese
author_facet Mariane dos Santos
Priscila Tamar Poletti
Gaia Favero
Alessandra Stacchiotti
Francesca Bonomini
Carolina Caruccio Montanari
Silvia Regina Bona
Norma Possa Marroni
Rita Rezzani
Francisco Veríssimo Veronese
author_sort Mariane dos Santos
collection DOAJ
description Introduction: Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus. As murine models of LN are valuable tools to better understand its pathophysiology and to search for new effective treatments, we investigated the effects of the bioflavonoid quercetin on pristane-induced LN mice through histomorphological analyses. Methods: Immunofluorescence and biochemical assays were used to evaluate the expression of markers of inflammation (interleukin-6, IL-6; tumour necrosis factor-α, TNF-α), oxidative stress (catalase, CAT; superoxide dismutase 1, SOD1; thiobarbituric acid reactive substances, TBARS), apoptosis (Bax), and fibrosis (transforming growth factor-β1, TGF-β1). Glomerular and tubular ultrastructure was analysed, and tissue messenger RNA of podocin, podoplanin and α3β1-integrin were quantified using the real-time polymerase chain reaction. Results: Pristane-induced LN mice showed severe kidney injury, characterized by increased proteinuria, glomerular mesangial expansion and inflammation, high expression of the pro-fibrotic, apoptotic and prooxidant markers and reduction of antioxidants. In the kidney ultrastructure, foot process (FP) effacement, apoptotic mesangial cells and abnormal mitochondria with disrupted cristae were observed, along with suppressed tissue mRNA of podocin, podoplanin and α3β1-integrin. Treatment with quercetin in the pristane-induced LN mice model was nephroprotective, decreasing proteinuria levels and significantly lowering tissue expression of IL-6, TNF-α, TGF-β1, Bax and TBARS. Simultaneously, quercetin significantly increased CAT and SOD1 expressions in these mice. In addition, it was observed improvement of the kidney ultrastructure, and tissue mRNA of podocin, but not podoplanin and α3β1-integrin, was restored to the levels found in the control mice. Conclusion: In conclusion, these findings provide experimental evidence of the renoprotective effects of quercetin in the pristane-induced LN mice model. We suggest that quercetin effectively ameliorates the kidney damage caused by pristane, a bioflavonoid to be further evaluated as a new therapeutic strategy in this disease.
first_indexed 2024-03-12T00:35:12Z
format Article
id doaj.art-7aff048da3844f2a8ae88275ee3aa041
institution Directory Open Access Journal
issn 0891-6934
1607-842X
language English
last_indexed 2024-03-12T00:35:12Z
publishDate 2018-02-01
publisher Taylor & Francis Group
record_format Article
series Autoimmunity
spelling doaj.art-7aff048da3844f2a8ae88275ee3aa0412023-09-15T10:01:07ZengTaylor & Francis GroupAutoimmunity0891-69341607-842X2018-02-01512698010.1080/08916934.2018.14428281442828Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritisMariane dos Santos0Priscila Tamar Poletti1Gaia Favero2Alessandra Stacchiotti3Francesca Bonomini4Carolina Caruccio Montanari5Silvia Regina Bona6Norma Possa Marroni7Rita Rezzani8Francisco Veríssimo Veronese9Universidade Federal do Rio Grande do SulUniversidade Federal do Rio Grande do SulUniversity of BresciaUniversity of BresciaUniversity of BresciaUniversidade Federal do Rio Grande do SulHospital de Clínicas de Porto AlegreHospital de Clínicas de Porto AlegreUniversity of BresciaUniversidade Federal do Rio Grande do SulIntroduction: Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus. As murine models of LN are valuable tools to better understand its pathophysiology and to search for new effective treatments, we investigated the effects of the bioflavonoid quercetin on pristane-induced LN mice through histomorphological analyses. Methods: Immunofluorescence and biochemical assays were used to evaluate the expression of markers of inflammation (interleukin-6, IL-6; tumour necrosis factor-α, TNF-α), oxidative stress (catalase, CAT; superoxide dismutase 1, SOD1; thiobarbituric acid reactive substances, TBARS), apoptosis (Bax), and fibrosis (transforming growth factor-β1, TGF-β1). Glomerular and tubular ultrastructure was analysed, and tissue messenger RNA of podocin, podoplanin and α3β1-integrin were quantified using the real-time polymerase chain reaction. Results: Pristane-induced LN mice showed severe kidney injury, characterized by increased proteinuria, glomerular mesangial expansion and inflammation, high expression of the pro-fibrotic, apoptotic and prooxidant markers and reduction of antioxidants. In the kidney ultrastructure, foot process (FP) effacement, apoptotic mesangial cells and abnormal mitochondria with disrupted cristae were observed, along with suppressed tissue mRNA of podocin, podoplanin and α3β1-integrin. Treatment with quercetin in the pristane-induced LN mice model was nephroprotective, decreasing proteinuria levels and significantly lowering tissue expression of IL-6, TNF-α, TGF-β1, Bax and TBARS. Simultaneously, quercetin significantly increased CAT and SOD1 expressions in these mice. In addition, it was observed improvement of the kidney ultrastructure, and tissue mRNA of podocin, but not podoplanin and α3β1-integrin, was restored to the levels found in the control mice. Conclusion: In conclusion, these findings provide experimental evidence of the renoprotective effects of quercetin in the pristane-induced LN mice model. We suggest that quercetin effectively ameliorates the kidney damage caused by pristane, a bioflavonoid to be further evaluated as a new therapeutic strategy in this disease.http://dx.doi.org/10.1080/08916934.2018.1442828lupus nephritispristanequercetininflammationoxidative stresspodocyte
spellingShingle Mariane dos Santos
Priscila Tamar Poletti
Gaia Favero
Alessandra Stacchiotti
Francesca Bonomini
Carolina Caruccio Montanari
Silvia Regina Bona
Norma Possa Marroni
Rita Rezzani
Francisco Veríssimo Veronese
Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
Autoimmunity
lupus nephritis
pristane
quercetin
inflammation
oxidative stress
podocyte
title Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
title_full Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
title_fullStr Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
title_full_unstemmed Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
title_short Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis
title_sort protective effects of quercetin treatment in a pristane induced mouse model of lupus nephritis
topic lupus nephritis
pristane
quercetin
inflammation
oxidative stress
podocyte
url http://dx.doi.org/10.1080/08916934.2018.1442828
work_keys_str_mv AT marianedossantos protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT priscilatamarpoletti protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT gaiafavero protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT alessandrastacchiotti protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT francescabonomini protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT carolinacarucciomontanari protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT silviareginabona protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT normapossamarroni protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT ritarezzani protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis
AT franciscoverissimoveronese protectiveeffectsofquercetintreatmentinapristaneinducedmousemodeloflupusnephritis